Secondary amyloidosis associated with systemic lupus erythematosus has rarely been reported. A 57-year-old female had been diagnosed as having possible systemic lupus erythematosus, although her clinical course was not typical. About one year after the diagnosis, treatment was begun with prednisolone because of progressive renal dysfunction, thrombocytopenia and low serum levels of complements. Recurrent diarrhea and gastrointestinal bleeding soon developed, then amyloidosis was revealed in the stomach and duodenum.Postmortemexamination confirmed systemic amyloidosis. Wediscuss the significance of this rare association of systemic lupus erythematosus and secondary amyloidosis. (Internal Medicine 32: 391-394, 1993) 
Introduction
Secondary amyloidosis is a well-recognized complication of chronic inflammatory, rheumatic and malignant diseases (1, 2) . However, the association of amyloidosis and systemic lupus erythematosus (SLE) seems very unusual (3, 4) . In most of the reported cases, the patients had suffered from longstanding SLE (5 , 6) or another well-known amyloid-associated disorder in addition to SLE (7, 8) . In this case, secondary amyloidosis was acutely developed with symptomsof diarrhea and gastrointestinal bleeding in a patient who had been diagnosed as having possible SLE.
Case Report
A 57-year-old female was referred to the hospital for evaluation of an abnormal chest shadow in October 1989 (Fig. l) . On admission she also had slight pain in her left wrist associated with morning stiffness for ten minutes, although she had no respiratory complaints. Three years previously, she had had transient polyarticular arthralgia and been treated with traditional Chinese medicine. There was a history of appendectomy whenshe was twenty years old. She had had hypertension and been treated with antihypertensive drugs for one year. almost all glomeruli showed hyalinosis due to sclerosis. In the remaining glomeruli, mesangial cell proliferation and some thickening of the basement membrane were found (Fig. 2) . On immunofluorescence examination, depositions of IgM, Clq and C3 were noted along the basement membrane and in the mesangium. These histopathological findings were defined as lupus nephritis, and classified as category VI, advanced sclerosing glomerulonephritis. Amyloid deposits were not detected at that time. A diagnosis of SLEwas highly suspected, based on the presence of arthritis , proteinuria, thrombocytopenia, and positive tests for antinuclear antibodies and anti-DNA, consisting with interstitial pneumonia and lupus nephritis. She was discharged in fair clinical condition without any treatment such as steroids in February 1990. Eleven months later she wasreadmitted because of bronchopneumonia, which was improved by administration of antibiotics. At that time, the ESR was 80 mmin the 1sthour, RBCwas 370xl04/|il, Hb was 10.4 g/dl. Antinuclear antibodies were positive with a titre of 1 : 160 with homogenous and speckled pattern and anti-DNA antibodies were negative. CH50was 33.3 U/ml. Since diarrhea developed during the subsequent weeks, upper gastrointestinal endoscopy and colon endoscopy were performed; these showed no abnormalities except for somelinear erosions in the antrum of the stomach. In February 1991 treatment with 60 mg/day of prednisolone was started because of progression of renal dysfunction (BUN; 57 mg/dl, Cr; 1.8 mg/dl, Ccr; 24.6 ml/min, total urinary protein; 1-1.5 g/day) and thrombocytopenia (1.0xl04/ml), lymphocytopenia (756/ml) and reduced serum levels ofcomplementcomponents (C3; 35 mg/dl, C4; 13 mg/dl), which were thought to be an exacerbation of SLE. The treatment with prednisolone did not result in improvement of these clinical features. Abdominal pain and melena developed at the beginning of April without abnormalities in clotting tests. Upper gastrointestinal endoscopy showeddiffuse reddish erosion and small excaved lesions in the antrum of the stomach and yellowish-white granular lesions in the descending part of duodenum (Figs. 3 and 4) . Biopsy specimens revealed massive amorphous deposition only in the submucosal vessels, which led to vessel wall thickening. This was confirmed to be amyloid deposition by Congo red staining (Fig. 5) . The gastric biopsy specimentaken three months previously was re-examined for the presence of amyloid, but no deposition Wasdetected. Blood transfusion was repeated and totally amounted to 3,000 ml against anemia caused by recurrent bleeding. However, her SLE and Amyloidosis general condition rapidly deteriorated and she died of sepsis with fungi at the end of April. At autopsy the diagnosis of systemic amyloidosis was confirmed with the deposition of amyloid in the total gastrointestinal tract, kidneys, liver, heart, spleen, skin and other connective tissues. These amyloid deposits lost their stainability with Congored after treatment with potassium permanganate, which suggested that the amyloid was of the secondary (AA) type. In the kidney specimens massive amyloid deposits were found in vascular walls and glomeruli (Fig. 6) . Regarding the lung, pulmonary rlbrosis was revealed, showing honeycomb lung in the bilateral lower lobes.
Discussion
This patient fulfilled the 1982 revised American Rheumatism Association criteria for the classification of SLE(9), since she had symptomsof more than four of the necessary diagnostic criteria (arthritis without bone destruction, profuse proteinuria, lymphocytopenia and thrombocytopenia, positive anti-DNA antibodies and positive antinuclear antibodies). Histopathological findings of her renal biopsy specimen were consistent with lupus nephritis. Concerning her interstitial pneumonia, elevation of CD4/8 ratio is not consistent with someprevious reports demonstrating decreased CD4/8ratio in SLE, although its diagnostic value is still controversial (10, 1 1). The reasons for the high CD4/8 in the present case may be explained by the atypical interstitial pneumonia leading to rlbrosis for SLE and the patient's old age. Secondary amyloidosis is a recognized complication of manylongstanding inflammatory diseases, including connective tissue disorders (1, 2) .
Surprisingly, however, the occurrence of amyloidosis in SLE seems very uncommon (3, 4) . In most of the previous cases, the patients suffered from longstanding SLE before amyloidosis developed (5, 6), or had another well-known amyloid-associated disease such as rheumatoid arthritis (7) or ankylosing spondylitis (8) . Although her clinical course was not typical for SLE, she did not have any other disorders known to be associated with amyloidosis, such as chronic infection or malignancy.
Webelieve that she developed AAamyloidosis as the result of her underlying active connective tissue disease categorized in SLE. Systemic lupus erythematosus itself rapidly progressed in the year after the diagnosis, and was followed by the acute occurrence of amyloidosis soon after steroid treatment was begun.
Proposed mechanisms of amyloid deposits in the course of SLEinclude the potential role of other autoimmune diseases, long-term effects of steroid treatment, and chance alone (4) . Although the particular reason is unknownin this case, it seems hard to ascribe the secondary amyloidosis to the treatment with prednisolone, because it was given only for a short time. Acute exacerbation ofSLE in three months mayhave had some effects on the development of amyloidosis, or amyloidosis may have madeher condition unresponsive to the steroid treatment. In this case the careful examination of gastrointestinal bleeding led to the ante-mortem diagnosis of secondary amyloidosis. Gastrointestinal involvement of amyloidosis is well recognized and is demonstrated in almost all patients with systemic amyloidosis (12) . However, early detection is very rare because it is sometimes asymptomatic, and symptomssuch as nausea, vomiting, abdominal pain, diarrhea or gastrointestinal bleeding are not pathognomonic. Bleeding problems are reported to be common,although usually mild, occurring in 41 % of amyloidosis cases, of which 1 8%included gastrointestinal tract bleeding ( 1 3). Our patient had repeated episodes ofmelena in the absence of any abnormalities in clotting tests. This suggested that the bleeding was caused by amyloid deposition in blood vessels rather than by coagulation abnormalities. Vascular fragility and obliteration of the lumen caused by amyloid deposition are thought to lead to bleeding. It is reported that significant gastrointestinal bleeding is fatal in 45% of such cases (14) , although renal failure is the most commoncause of death (15) . In this case, the sudden development of melena in addition to the progressive renal dysfunction were the factors leading to a clinical clue suggestive of the superimposition of amyloidosis. There is a possibility that her inveterate diarrhea preceding gastrointestinal bleeding was the initial symptomof amyloid deposits in the intestinal walls and autonomic nerves, which resulted in impaired motor activities. However, it is difficult to implicate amyloidosis as the only cause of renal dysfunction considering concomitant global sclerosis and lupus nephritis, which were confirmed in the renal biopsy specimens. Thus, our experience suggests that, although rare, amyloidosis should be a diagnostic consideration when patients with SLE have recurrent undiagnosed diarrhea or gastrointestinal bleeding.
